James Knight
Corporate Officer/Principal presso SYNACT PHARMA AB
Patrimonio netto: 52 365 $ in data 30/06/2024
Provenienza dei contatti di primo grado di James Knight
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.
48
| Subsidiary | Pharmaceuticals: Major | 48 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Medical/Nursing Services | 13 | |
| Subsidiary | Pharmaceuticals: Major | 11 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a James Knight tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMGEN INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal President President Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Executive Officer Director of Finance/CFO | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member President Director/Board Member Chairman | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal General Counsel Corporate Officer/Principal Director/Board Member Comptroller/Controller/Auditor Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Compliance Officer Director/Board Member Human Resources Officer | |
| ZOGENIX, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Sales & Marketing | |
| SHIRE | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chairman General Counsel Director/Board Member Director/Board Member Compliance Officer | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree | |
| San Diego State University | College/University | Graduate Degree Undergraduate Degree | |
| The California State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Wisconsin | College/University | Graduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| TXP Pharma GmbH | Founder Chief Executive Officer Founder Founder | ||
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer Sales & Marketing | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Human Resources Officer General Counsel | |
| PROTHENA CORPORATION PLC | Biotechnology | Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of Lund | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Haas School of Business | College/University | Masters Business Admin Undergraduate Degree | |
| OTONOMY | Biotechnology | Director/Board Member Compliance Officer | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member General Counsel | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 37 |
| Irlanda | 6 |
| Svezia | 4 |
| Danimarca | 3 |
| Canada | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 14 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 284 |
| Corporate Officer/Principal | 188 |
| Chief Executive Officer | 85 |
| Independent Dir/Board Member | 77 |
| Chief Tech/Sci/R&D Officer | 69 |
Contatti più connessi
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| Torbjørn Bjerke | 27 |
| Jeppe Øvlesen | 27 |
| Todd Davis | 23 |
| Lars Ekman | 21 |
| Björn Westberg | 21 |
| George Martin | 21 |
| Uli Alf Hacksell | 20 |
| Terje Kalland | 20 |
| Brian Kotzin | 20 |
| Nancy Lurker | 20 |
| Scott Whitcup | 18 |
| Richard H. Chin | 17 |
| Nils Thomas von Koch | 17 |
| Shalini Sharp | 17 |
- Borsa valori
- Insiders
- James Knight
- Connessioni Società
